Fractional CO₂ laser combined with intradermal and topical platelet-rich plasma for hypertrophic scars: a randomized controlled trial
Lasers in Medical Science · 2026
DOI: 10.1007/s10103-026-05071-4 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Lasers in Medical Science, 2026. Verfasst von Junjie Sun und 4 weiteren Autor:innen. Beteiligte Einrichtung: Geriatric Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Platelet-Rich Plasma, Cicatrix, Hypertrophic, Lasers, Gas, Low-Level Light Therapy. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Purpose
This study compared the clinical efficacy and safety of fractional CO₂ laser combined with platelet-rich plasma (PRP) delivered by intradermal injection plus topical application versus fractional CO₂ laser alone for the treatment of hypertrophic scars.
Methods
In this prospective, randomized, assessor-blinded trial, 120 patients were assigned to a combined group (laser + PRP, n = 60) or a control group (laser + saline, n = 60). Four sessions were delivered at 4–6-week intervals. The primary outcome was Vancouver Scar Scale (VSS) total score. The prespecified primary endpoint was the between-group difference in VSS total score at T4 (6 months after the final treatment session). Secondary outcomes included POSAS scores, ultrasound-measured scar thickness, patient satisfaction, and adverse events.
Results
Both groups showed significant VSS improvement (both P < 0.001). The combined group had significantly lower VSS total scores than the control group from T1 onward (P = 0.036 at T1; P < 0.001 at T2 and T4; P = 0.007 at T3; estimated between-group difference at T4 -1.85 points, 95% CI -2.48 to -1.22, from the primary mixed-effects model) and lower POSAS scores from T1 onward (P = 0.022 at T1; P < 0.001 at T2, T3, and T4) than the control group. Ultrasound-measured scar thickness was lower in the combined group at 3 months (P = 0.045); at 6 months the difference was attenuated and of borderline statistical significance (P = 0.042–0.065 across missing-data approaches). Patient satisfaction was higher in the combined group (P < 0.001). Procedural pain was greater in the combined group (mean between-group difference 1.34 points on a 0–10 VAS; P < 0.001). Post-inflammatory hyperpigmentation was numerically lower in the combined group (18.33% vs. 33.33%; P = 0.094).
Conclusion
Fractional CO₂ laser combined with intradermal and topical PRP provided greater improvement in clinical scar scores than laser alone, with an acceptable safety profile. The advantage in ultrasound-measured thickness at 6 months was of borderline statistical significance. These findings support PRP as a potential adjunct for hypertrophic scars.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Geriatric Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, China.
- Wuhan Wuchang Hospital, Wuhan, China.
- Yangyuan Second Community Health Service Center of Wuchang District, Wuhan, China. sunyyjun@163.com.
Zitieren
APA
Sun, J., Wang, J., Song, S., Liu, X., & Fu, W. (2026). Fractional CO₂ laser combined with intradermal and topical platelet-rich plasma for hypertrophic scars: a randomized controlled trial. Lasers in Medical Science. https://doi.org/10.1007/s10103-026-05071-4
Vancouver
Sun J, Wang J, Song S, Liu X, Fu W. Fractional CO₂ laser combined with intradermal and topical platelet-rich plasma for hypertrophic scars: a randomized controlled trial. Lasers in Medical Science. 2026. doi:10.1007/s10103-026-05071-4
BibTeX
@article{Sun2026,
author = {Sun, Junjie and Wang, Jun and Song, Shujun and Liu, Xiaolin and Fu, Wenli},
title = {Fractional CO₂ laser combined with intradermal and topical platelet-rich plasma for hypertrophic scars: a randomized controlled trial},
journal = {Lasers in Medical Science},
year = {2026},
doi = {10.1007/s10103-026-05071-4}
}
EUVIMED